DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Isoquinoline is an investigational drug.
There have been 11 clinical trials for Isoquinoline. The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2018.
The most common disease conditions in clinical trials are Cysticercosis, HIV Infections, and Taeniasis. The leading clinical trial sponsors are National Institute of Mental Health (NIMH), Tianjin Anding Hospital, and xiaohua li.
There are nine hundred and ninety-five US patents protecting this investigational drug and nine international patents.
Recent Clinical Trials for Isoquinoline
|Comparation of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients||Tianjin Anding Hospital||Phase 4|
|Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail Approach||National Center for Complementary and Integrative Health (NCCIH)||Early Phase 1|
|Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail Approach||Washington State University||Early Phase 1|
Top disease conditions for Isoquinoline
Top clinical trial sponsors for Isoquinoline
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Isoquinoline||Start Trial||Production method of 1, 2, 4-triazole compound||Sumitomo Chemical Company, Limited (Tokyo, JP)||Start Trial|
|Isoquinoline||Start Trial||Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitors||Bristol-Myers Squibb Company (Princeton, NJ)||Start Trial|
|Isoquinoline||Start Trial||Crystalline dimethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarb- oxylate||Shionogi & Co., Ltd (JP)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Isoquinoline||European Patent Office||2766345||2031-10-14||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|